| | | | | |
ORMP Oramed Pharmaceuticals Inc. | $5.0750 | +4.64% | $209.23M | $99.72K | |
OSG Octave Specialty Group, Inc. | $4.5450 | +0.11% | $209.03M | $319.22K | |
| $62.9100 | +2.36% | $208.63M | $10.11K | |
| $5.8800 | -0.51% | $208.50M | $264.20K | |
ANTA Antalpha Platform Holding Company Class A Ordinary Shares | $3.7350 | -4.23% | $208.49M | $291.00 | |
CMRC Commerce.com, Inc. Series 1 Common Stock | $2.4650 | +4.45% | $207.14M | $376.93K | |
CHCI Comstock Holding Companies, Inc. Class A | $20.1350 | +1.49% | $206.15M | $11.83K | |
AESP Aeon Acquisition I Corp. Class A Ordinary Shares | $9.9700 | -0.01% | $206.11M | $113.00K | |
TVIV Texas Ventures Acquisition IV Corp Class A Ordinary Shares | $9.9400 | +0.20% | $205.42M | $40.00 | |
NPV Nuveen Virginia Quality Municipal Income Fund | $10.2880 | -0.60% | $205.21M | $69.97K | |
WLII Willow Lane Acquisition Corp. II Class A Ordinary Shares | $10.2450 | -0.15% | $204.71M | $12.00 | |
PLX Protalix BioTherapeutics, Inc. Common Stock | $2.6050 | +0.58% | $204.65M | $209.07K | |
| $7.2400 | +1.97% | $204.50M | $37.77K | |
ANGI Angi Inc. Class A Common Stock | $4.8850 | +4.72% | $204.40M | $330.48K | |
| $7.2750 | -0.75% | $203.13M | $72.45K | |
